Literature DB >> 3760562

Growth inhibition and cytotoxicity of tumor necrosis factor in L929 cells is enhanced by high cell density and inhibition of mRNA synthesis.

M Kirstein, W Fiers, C Baglioni.   

Abstract

L929 cells were growth-inhibited after 1 to 2 days of treatment with human recombinant tumor necrosis factor (rTNF). This effect of rTNF was largely reversible, and L929 cells resumed normal growth when rTNF was removed. The rTNF showed growth inhibitory and cytotoxic activity when L929 cells approached a high cell density and grew slowly. This was shown in experiments in which L929 cells approached confluency at different times after being seeded at increasing initial densities. The rTNF had little effect on the growth of cells seeded at the lowest density tested. L929 cells cultured to high density synthesized RNA at a reduced rate. This suggested that a reduced rate of RNA synthesis may be at least in part responsible for the growth inhibitory and cytotoxic activities of rTNF on cells grown to high density. Treatment with inhibitors of RNA synthesis potentiated the cytotoxic activity of rTNF. Inhibition of mRNA synthesis was apparently responsible for the enhanced sensitivity to rTNF, as shown by experiments with 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole, an inhibitor of the synthesis of poly(A)-containing RNA.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3760562

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Glutathione and the rate of cellular proliferation determine tumour cell sensitivity to tumour necrosis factor in vivo.

Authors:  E Obrador; J Navarro; J Mompo; M Asensi; J A Pellicer; J M Estrela
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

2.  Tumor necrosis factor expression in human epithelial tumor cell lines.

Authors:  D R Spriggs; K Imamura; C Rodriguez; E Sariban; D W Kufe
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

3.  Effect of recombinant tumour necrosis factor on acute infection in mice with Toxoplasma gondii or Trypanosoma cruzi.

Authors:  C M Black; D M Israelski; Y Suzuki; J S Remington
Journal:  Immunology       Date:  1989-12       Impact factor: 7.397

4.  Induction of tumor necrosis factor expression and resistance in a human breast tumor cell line.

Authors:  D Spriggs; K Imamura; C Rodriguez; J Horiguchi; D W Kufe
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

5.  Sensitivity to tumour necrosis factor-mediated cytolysis is unrelated to manganous superoxide dismutase messenger RNA levels among transformed mouse fibroblasts.

Authors:  J M Boss; S M Laster; L R Gooding
Journal:  Immunology       Date:  1991-07       Impact factor: 7.397

6.  A protein serologically and functionally related to the group C E3 14,700-kilodalton protein is found in multiple adenovirus serotypes.

Authors:  T M Horton; A E Tollefson; W S Wold; L R Gooding
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

7.  Dual signaling of the Fas receptor: initiation of both apoptotic and necrotic cell death pathways.

Authors:  D Vercammen; G Brouckaert; G Denecker; M Van de Craen; W Declercq; W Fiers; P Vandenabeele
Journal:  J Exp Med       Date:  1998-09-07       Impact factor: 14.307

8.  Cytotoxic, Apoptotic and Genotoxic Effects of Lipid-Based and Polymeric Nano Micelles, an In Vitro Evaluation.

Authors:  Fatemeh Bahadori; Abdurrahim Kocyigit; Hayat Onyuksel; Aydan Dag; Gulacti Topcu
Journal:  Toxics       Date:  2017-12-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.